The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 765K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

69 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
48
Design of Potent Small-Molecule Stimulator of Interferon Gene Inhibitor and Stimulator of Interferon Gene Mutant-Specific Degrader.EBI
University of Michigan
25
Synthesis and structure-activity evaluation of a series of novel tricyclic STING activators.EBI
Curadev Pharma Pvt. Ltd.
3
Design, synthesis, and activity evaluation of novel STING inhibitors based on C170 and H151.EBI
Ocean University of China
53
Design of an Oral STING Agonist through Intramolecular Hydrogen Bond Ring Mimicking to Achieve Complete Tumor Regression.EBI
University of Michigan
24
Discovery of 3-(Fluoro-imidazolyl)pyridazine Derivatives as Potent STING Agonists with Antitumor Activity.EBI
Chinese Academy of Sciences
27
Design, Synthesis, and Biological Evaluation of Selective STING Synergists That Enhance cGAMP-STING Pathway Activation without Inherent Agonist Activity.EBI
Beijing Institute of Pharmacology & Toxicology
36
Discovery of an Orally Bioavailable STING Inhibitor with In Vivo Anti-Inflammatory Activity in Mice with STING-Mediated Inflammation.EBI
China Pharmaceutical University
44
Discovery of Potent STING Inhibitors Bearing a Difluorobenzodioxol Structural Motif as Potent Anti-Inflammatory Agents.EBI
Shanghai Jiao Tong University
4
Orally Bioavailable and Site-Selective Covalent STING Inhibitor Derived from a Macrocyclic Marine Diterpenoid.EBI
National Health Research Institutes
8
Discovery of novel amidobenzimidazole derivatives as orally available small molecule modulators of stimulator of interferon genes for cancer immunotherapy.EBI
Korea Research Institute of Chemical Technology
18
Vinylphosphonate-based cyclic dinucleotides enhance STING-mediated cancer immunotherapy.EBI
Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences
2
Design and Assessment of First-Generation Heterobifunctional PPARα/STING Modulators.EBI
University of Minnesota
20
Non-kinase off-target inhibitory activities of clinically-relevant kinase inhibitors.EBI
Purdue University
3
Perspectives on Nuclear Magnetic Resonance Spectroscopy in Drug Discovery Research.EBI
Bristol Myers Squibb
5
PDE-stable 2'3'-cGAMP analogues, containing 5'-S-phosphorothioester linkage, as STING agonists.EBI
Purdue University
15
Macrocyclization strategy for improving candidate profiles in medicinal chemistry.EBI
Gachon University
13
Analysis of structure-activity relationship of indol-3-yl-N-phenylcarbamic amides as potent STING inhibitors.EBI
National Health Research Institutes
71
Development of Orally Bioavailable Amidobenzimidazole Analogues Targeting Stimulator of Interferon Gene (STING) Receptor.EBI
China Pharmaceutical University
22
Structure-Activity Relationship Study of 1EBI
University of Chinese Academy of Sciences
25
Discovery and Optimization of a STING Agonist Platform for Application in Antibody Drug Conjugates.EBI
Mersana Therapeutics
6
S-acylthioalkyl ester (SATE)-based prodrugs of deoxyribose cyclic dinucleotides (dCDNs) as the STING agonist for antitumor immunotherapy.EBI
Nankai University
14
Discovery of BI 7446: A Potent Cyclic Dinucleotide STING Agonist with Broad-Spectrum Variant Activity for the Treatment of Cancer.EBI
Boehringer Ingelheim Pharma
89
Structure-activity relationship study of amidobenzimidazole derivatives as stimulator of interferon genes (STING) agonists.EBI
Peking Union Medical College
9
A comprehensive review on acridone based derivatives as future anti-cancer agents and their structure activity relationships.EBI
Svkm'S Nmims
3
STING antagonists, synthesized EBI
Purdue University
28
Design, Synthesis, and Biological Evaluation of Bipyridazine Derivatives as Stimulator of Interferon Genes (STING) Receptor Agonists.EBI
Fudan University
3
Identification of (-)-Epigallocateshin gallate derivatives promoting innate immune activation via 2',3'-cyclic GMP-AMP-stimulator of interferon genes pathway.EBI
Korea Institute of Science and Technology
50
If small molecules immunotherapy comes, can the prime be far behind?EBI
Zhejiang University
2
Discovery of Selenium-Containing STING Agonists as Orally Available Antitumor Agents.EBI
China Pharmaceutical University
1
Novel CRBN-Recruiting Proteolysis-Targeting Chimeras as Degraders of Stimulator of Interferon Genes with In Vivo Anti-Inflammatory Efficacy.EBI
Southern Medical University
21
Discovery of MK-1454: A Potent Cyclic Dinucleotide Stimulator of Interferon Genes Agonist for the Treatment of Cancer.EBI
Merck
21
Development of Potent Immune Modulators Targeting Stimulator of Interferon Genes Receptor.EBI
Korea Research Institute of Chemical Technology
22
Discovery of novel Thieno[2,3-d]imidazole derivatives as agonists of human STING for antitumor immunotherapy using systemic administration.EBI
China Pharmaceutical University
6
Structure-Activity relationship study of benzothiophene oxobutanoic acid analogues leading to novel stimulator of interferon gene (STING) agonists.EBI
Shanghai Jiao Tong University
25
Small molecule approaches to treat autoimmune and inflammatory diseases (Part II): Nucleic acid sensing antagonists and inhibitors.EBI
Roche Innovation Center Shanghai
18
STING, a promising target for small molecular immune modulator: A review.EBI
China Pharmaceutical University
23
Discovery of Non-Nucleotide Small-Molecule STING Agonists EBI
Bristol Myers Squibb
21
Identification of Novel Carbocyclic Pyrimidine Cyclic Dinucleotide STING Agonists for Antitumor Immunotherapy Using Systemic Intravenous Route.EBI
Takeda Pharmaceuticals International
25
Synthesis and Biological Evaluation of Phosphoester and Phosphorothioate Prodrugs of STING Agonist 3',3'-c-Di(2'F,2'dAMP).EBI
Institute of Organic Chemistry and Biochemistry of The Czech Academy of Sciences
17
Structure-Activity Relationship Study of Amidobenzimidazole Analogues Leading to Potent and Systemically Administrable Stimulator of Interferon Gene (STING) Agonists.EBI
Chinese Academy of Sciences
2
The discovery of potent small molecule activators of human STING.EBI
Curadev Pharma
13
Design, Synthesis, and Biological Evaluation of Novel Cyclic Adenosine-Inosine Monophosphate (cAIMP) Analogs That Activate Stimulator of Interferon Genes (STING).EBI
Invivogen
10
Targeting Stimulator of Interferon Genes (STING) for the Potential Treatment of Cancer and Infectious Diseases.EBI
Usona Institute
7
Synthesis and biological evaluation of all possible inosine-mixed cyclic dinucleotides that activate different hSTING variants.EBI
Nankai University
6
Novel Compounds as STING Modulators for Treating Hepatitis B Virus Infections.EBI
Smith, Gambrell & Russell
6
Potential Cancer Treatment by Agonists of the Stimulator of Interferon Genes.EBI
Therachem Research Medilab
13
Discovery of a Novel cGAMP Competitive Ligand of the Inactive Form of STING.EBI
Merck
28
Targeting Stimulator of Interferon Genes (STING): A Medicinal Chemistry Perspective.EBI
China Pharmaceutical University
39
Enzymatic Preparation of 2'-5',3'-5'-Cyclic Dinucleotides, Their Binding Properties to Stimulator of Interferon Genes Adaptor Protein, and Structure/Activity Correlations.EBI
Institute of Organic Chemistry and Biochemistry of The Czech Academy of Sciences and Gilead Sciences Research Centre At Iocb
2
STING modulators: Predictive significance in drug discovery.EBI
Zhejiang Normal University
47
Design, Synthesis, and Biological Evaluation of Amidobenzimidazole Derivatives as Stimulator of Interferon Genes (STING) Receptor Agonists.EBI
Peking Union Medical College
17
Macrolide derivatives, preparation method and application thereofBDB
Zhejiang Hisun Pharmaceutical
6
KRAS INHIBITOR COMPOUNDBDB
Shanghai Apeiron Therapeutics Company
100
PYRIMIDINES AND METHODS OF THEIR USEBDB
Kineta
22
COMPOSITION AND METHOD FOR TREATMENT OF GRAM NEGATIVE BACTERIAL INFECTIONBDB
The State University of New York
15
Decarboxylase inhibitors for treating Parkinson's diseaseBDB
Sail Biomedicines
5
Pyridopyrimidine derivative, preparation method therefor and medical use thereofBDB
Jiangsu Hengrui Medicine Co.
22
PREPARATION AND APPLICATION METHOD OF HETEROCYCLIC COMPOUNDS AS KRAS INHIBITORBDB
Shanghai Kechow Pharma
44
NAPHTHYRIDINE AND PYRIDO[3,4-c]PYRIDAZINE DERIVATIVES AS GABAA ALPHA 5 RECEPTOR MODULATORSBDB
Richter Gedeon
163
QUINAZOLINONES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAMEBDB
Repare Therapeutics
252
Pyrazole MAGL inhibitorsBDB
H. Lundbeck
13
Bipyrazole derivatives as JAK inhibitorsBDB
Incyte
25
Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, Rasopathies, and fibrotic diseaseBDB
Shy Therapeutics
137
Compounds and methods useful in the treatment of a PRMT5-mediated disorderBDB
Argonaut Therapeutics
71
Imidazopyridazine and imidazopyridine compounds and uses thereofBDB
Incyte
4
Amide derivatives as Nav1.7 and Nav1.8 blockersBDB
Raqualia Pharma
3
PRMT5 inhibitorsBDB
Ctxt
294
Pyrimidine derivativeBDB
ASKA Pharmaceutical Co